0001209191-19-029396.txt : 20190513 0001209191-19-029396.hdr.sgml : 20190513 20190513171259 ACCESSION NUMBER: 0001209191-19-029396 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20190509 FILED AS OF DATE: 20190513 DATE AS OF CHANGE: 20190513 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Florence Anthony A. Jr. CENTRAL INDEX KEY: 0001559827 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-38886 FILM NUMBER: 19819335 MAIL ADDRESS: STREET 1: 5425 WISCONSIN AVENUE, SUITE 800 CITY: CHEVY CHASE STATE: MD ZIP: 20815 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Trevi Therapeutics, Inc. CENTRAL INDEX KEY: 0001563880 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 450834299 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 195 CHURCH STREET STREET 2: 14TH FLOOR CITY: NEW HAVEN STATE: CT ZIP: 06510 BUSINESS PHONE: 203-304-2499 MAIL ADDRESS: STREET 1: 195 CHURCH STREET STREET 2: 14TH FLOOR CITY: NEW HAVEN STATE: CT ZIP: 06510 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2019-05-09 0 0001563880 Trevi Therapeutics, Inc. TRVI 0001559827 Florence Anthony A. Jr. 5425 WISCONSIN AVENUE SUITE 800 CHEVY CHASE MD 20815 0 0 1 0 Common Stock 2019-05-09 4 C 0 1938562 A 1938562 I See Note 2 Common Stock 2019-05-09 4 P 0 1000000 10.00 A 2938562 I See Note 2 Common Stock 2019-05-09 4 P 0 1500000 10.00 A 4438562 I See Note 2 Series C Preferred Stock 2019-05-09 4 C 0 17099315 0.00 D Common Stock 1938562 0 I See Note 2 On May 9, 2019, the Series C Preferred Stock, and the dividends that had accrued thereon to date, converted into Common Stock on a 9.5-for-one basis without payment of further consideration automatically upon the closing of the Issuer's initial public offering. The shares had no expiration date. The Reporting Person is a manager of NEA 16 GP, LLC, ("NEA 16 GP") which is the sole general partner of NEA Partners 16, L.P. ("NEA Partners 16"). NEA Partners 16 is the sole general partner of New Enterprise Associates 16, L.P. ("NEA 16"), which is the direct beneficial owner of the shares. The Reporting Person disclaims beneficial ownership within the meaning of Section 16 of the Securities Exchange Act of 1934, as amended, or otherwise of such portion of the shares held by NEA 16 in which the Reporting Person has no pecuniary interest. Acquired from the Issuer pursuant to a Securities Purchase Agreement dated May 6, 2019 with a closing date of May 9, 2019. /s/ Sasha Keough, attorney-in-fact 2019-05-13